Roe F J, Dipple A, Mitchley B C
Br J Cancer. 1972 Dec;26(6):461-5. doi: 10.1038/bjc.1972.63.
Equimolar doses of 7-methylbenz(a)anthracene and 3 of its derivatives were given to newborn male and female Swiss mice. All 4 substances tested increased the risk of tumour development compared with that seen in control mice given the vehicle, arachis oil, only.7-Methylbenz(a)anthracene itself was the most actively tumorigenic of the compounds studied, giving rise to subcutaneous sarcomata at the site of injection, and multiple lung tumours and liver tumours. 7-Bromomethyl-12-methylbenz(a)-anthracene was similarly active in the lung and liver but evoked fewer subcutaneous sarcomata. 7-Bromomethylbenz(a)anthracene was seemingly slightly less active than either 7-methylbenz(a)anthracene or 7-bromomethyl-12-methylbenz(a)anthracene. 4-Chloro-7-bromomethylbenz(a)anthracene exhibited only marginal activity in that it slightly increased the risk of liver tumour development in male mice.
将等摩尔剂量的7-甲基苯并(a)蒽及其3种衍生物给予新生的雄性和雌性瑞士小鼠。与仅给予赋形剂花生油的对照小鼠相比,所有4种受试物质均增加了肿瘤发生的风险。7-甲基苯并(a)蒽本身是所研究化合物中最具活性的致瘤物质,在注射部位引发皮下肉瘤、多发性肺肿瘤和肝肿瘤。7-溴甲基-12-甲基苯并(a)蒽在肺和肝中同样具有活性,但诱发的皮下肉瘤较少。7-溴甲基苯并(a)蒽的活性似乎略低于7-甲基苯并(a)蒽或7-溴甲基-12-甲基苯并(a)蒽。4-氯-7-溴甲基苯并(a)蒽仅表现出微弱的活性,即它略微增加了雄性小鼠肝肿瘤发生的风险。